Serum Institute

Australia says looking forward to welcoming Indian students after Covishield approval

Australia had imposed very strict travel restrictions on people travelling in and out of the country.

published on : 1st October 2021

Novavax asks WHO to grant emergency use approval to its COVID vaccine

Novavax and its partner the Serum Institute say their request for the COVID-19 vaccine to the UN health agency is based on a previous submission to Indian regulators.

published on : 24th September 2021

Confusion reigns over Covishield on UK's travel advisory as India not on eligibility list

So far it means, under the new rules from October 4, Indian travellers must take a COVID test three days before departure and book in advance for two COVID tests to be taken upon arrival in England.

published on : 22nd September 2021

SII to supply nearly 22 crore doses of Covishield vaccine to Centre in October

The Pune-based pharmaceutical company has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month.

published on : 21st September 2021

Biocon and Serum Institute come together with strategic alliance to increase vaccine access for developing countries

As part of the deal, the BBL has offered 15% stake to SILS at a post money valuation of $4.9 billion in exchange for committed access to 100 million doses of vaccines per annul for 15 years.

published on : 18th September 2021

Biocon-Serum alliance to build biotech powerhouse 

Research and manufacturing infrastructure will also be leveraged by this partnership for opportunities in infectious diseases,” Shaw said.

published on : 18th September 2021

SII to supply Inactivated Polio Vaccine to Centre for Universal Immunisation Programme

The Union Health Ministry has recently placed a purchase order with SII for 54 lakh doses of IPV vaccine.

published on : 14th September 2021

Centre places 66 crore Covishield doses order with SII to be supplied by December: Sources

Serum Institute of India has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month.

published on : 9th September 2021

Serum Institute informs Centre it will supply around 20 crore Covishield doses in September

In a production plan submitted to the Centre in May, SII's director had communicated that the production of Covishield would be ramped up to 10 crore each in August and September, sources had said.

published on : 26th August 2021

Serum Institute buys 50 per cent stake in pharma packaging firm Schott Kaisha

Serum Institute of India (SII) has bought 50 per cent stake in Schott Kaisha to become Schott's joint venture partner and secure pharma packaging supply, the statement said.

published on : 17th August 2021

Fighting COVID: Centre allocates Rs 267.35 crore to Kerala, allows purchasing of 10 lakh Covishield doses

The Centre had earlier allowed states and private hospitals to procure 50 per cent of the vaccines following demands for a decentralisation of the process.

published on : 16th August 2021

COVID vaccine export ban 'very bad' move; son warned not to speak against it: SII's Cyrus Poonawalla

Over 150 countries are dependent on the SII for vaccines and are blaming the company for stopping the supply during a crucial period, Cyrus Poonawalla said.

published on : 13th August 2021

No need to mix two COVID jabs: Serum Institute chairman Poonawalla against using cocktail of vaccines

The efficacy of this approach has not been proven in field trials involving thousands of participants, he said.

published on : 13th August 2021

Had to fall at bureaucrats' feet 50 years ago, but licence raj came down under Modi govt: Poonawalla

Licence raj culture has diminished, which has resulted in quick launch of the coronavirus vaccine, Serum Institute of India chairman Cyrus Poonawalla said.

published on : 13th August 2021

Single-dose Johnson and Johnson vaccine gets Indian drug regulator nod

J&J has tied up with Hyderabad-based Biological E for the global supply chain network, hoping to supply its Covid-19 vaccine Janssen through extensive collaborations and partnerships.

published on : 8th August 2021
1 2 3 4 5 6 >